XRP enters Nasdaq company's reserve

Wellgistics, the pharmaceutical company listed on Nasdaq, aims for fast and low-cost operations in the healthcare industry by adopting XRP as a means of payment and reserve.

Florida-based drug delivery company Wellgistics, listed on the Nasdaq stock exchange, announced that it will use XRP as both a means of payment and a treasury reserve asset. The company will use a $50 million loan to support this transformation.

According to the statement, Wellgistics aims to reduce transaction times to seconds and reduce costs on international money transfers for pharmacies, suppliers and manufacturers by integrating XRP beyond using it as a reserve asset. On traditional remittances, transaction times usually reach 3 days, while fees range from $10-30. The company emphasized that this system will enable compatible, fast and low-cost transactions on a global scale.

Brian Norton, CEO of Wellgistics, said, "We challenge the idea that healthcare should be connected to heavy-functioning, vehicle-filled systems." Norton also emphasized that success in the healthcare sector should no longer be sought in gigantic buildings, but in fast infrastructure and efficient digital systems: “We support infrastructure, not inertia.”

The company plans to use the $50 million loan not only for XRP integration, but also to research healthcare-specific programmable liquidity solutions and on-demand payment models.